4 years of historical data (2022–2025) · Technology · Semiconductors
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Astera Labs, Inc. Common Stock trades at 325.4x earnings, 139% above its 5-year average of 136.4x, sitting at the 100th percentile of its historical range. Compared to the Technology sector median P/E of 28.3x, the stock trades at a premium of 1048%. On a free-cash-flow basis, the stock trades at 239.8x P/FCF, 74% above the 5-year average of 137.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $67.6B | $29.9B | $17.4B | — | — |
| Enterprise Value | $67.4B | $29.7B | $17.3B | — | — |
| P/E Ratio → | 325.43 | 136.36 | — | — | — |
| P/S Ratio | 79.27 | 35.04 | 43.87 | — | — |
| P/B Ratio | 52.28 | 21.90 | 18.02 | — | — |
| P/FCF | 239.84 | 106.01 | 169.73 | — | — |
| P/OCF | 211.64 | 93.55 | 127.20 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Astera Labs, Inc. Common Stock's enterprise value stands at 374.2x EBITDA, 127% above its 5-year average of 165.0x. The Technology sector median is 16.5x, placing the stock at a 2166% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | 34.88 | 43.67 | — | — |
| EV / EBITDA | 374.18 | 164.98 | — | — | — |
| EV / EBIT | 388.91 | 136.32 | — | — | — |
| EV / FCF | — | 105.54 | 168.97 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Astera Labs, Inc. Common Stock earns an operating margin of 20.3%. Operating margins have expanded from -25.5% to 20.3% over the past 3 years, signaling improving operational efficiency. ROE of 18.8% indicates solid capital efficiency. ROIC of 12.3% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | 75.7% | 75.7% | 76.4% | 68.9% | 73.5% |
| Operating Margin | 20.3% | 20.3% | -29.3% | -25.5% | -75.4% |
| Net Profit Margin | 25.7% | 25.7% | -21.1% | -22.7% | -73.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | 18.8% | 18.8% | -14.9% | -72.8% | — |
| ROA | 16.9% | 16.9% | -13.3% | -12.9% | -27.6% |
| ROIC | 12.3% | 12.3% | -17.4% | -19.2% | — |
| ROCE | 14.7% | 14.7% | -20.6% | -17.7% | -35.1% |
Solvency and debt-coverage ratios — lower is generally safer
Astera Labs, Inc. Common Stock carries a Debt/EBITDA ratio of 0.2x, which is very conservative (93% below the sector average of 2.9x). The company holds a net cash position — cash of $168M exceeds total debt of $35M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.00 | 0.02 | — |
| Debt / EBITDA | 0.19 | 0.19 | — | — | — |
| Net Debt / Equity | — | -0.10 | -0.08 | -0.27 | — |
| Net Debt / EBITDA | -0.73 | -0.73 | — | — | — |
| Debt / FCF | — | -0.47 | -0.76 | — | — |
| Interest Coverage | — | — | — | — | — |
Net cash position: cash ($168M) exceeds total debt ($35M)
Short-term solvency ratios and asset-utilisation metrics
Astera Labs, Inc. Common Stock's current ratio of 10.24x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 9.79x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 5.30x to 10.24x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.24 | 10.24 | 11.71 | 5.30 | 5.14 |
| Quick Ratio | 9.79 | 9.79 | 11.21 | 4.61 | 4.42 |
| Cash Ratio | 8.94 | 8.94 | 10.56 | 4.26 | 4.07 |
| Asset Turnover | — | 0.56 | 0.38 | 0.59 | 0.38 |
| Inventory Turnover | 3.51 | 3.51 | 2.17 | 1.49 | 0.73 |
| Days Sales Outstanding | — | 35.62 | 35.75 | 26.27 | 48.99 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Astera Labs, Inc. Common Stock does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 0.3% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | 0.3% | 0.7% | — | — | — |
| FCF Yield | 0.4% | 0.9% | 0.6% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $180M | $131M | $153M | $130M |
Compare ALAB with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $68B | 325.4 | 374.2 | 239.8 | 75.7% | 20.3% | 18.8% | 12.3% | 0.2 | |
| $244B | 90.9 | 93.7 | 174.8 | 51.0% | 16.3% | 19.3% | 6.0% | 1.8 | |
| $8B | 20.1 | 15.2 | — | 52.8% | 23.0% | 20.3% | 22.9% | 0.3 | |
| $28B | -509.8 | 149.4 | 147.3 | 54.9% | 13.4% | -4.4% | 6.0% | 2.8 | |
| $10B | -689.7 | 94.4 | 82.4 | 46.4% | 4.8% | -1.6% | 2.8% | 2.6 | |
| $4B | -159.0 | — | — | 12.7% | -24.9% | -7.2% | -5.9% | — | |
| $4.8T | 40.8 | 36.4 | 50.1 | 71.1% | 60.4% | 101.5% | 81.8% | 0.1 | |
| $848B | 196.2 | 126.4 | 125.8 | 49.5% | 10.7% | 7.2% | 4.7% | 0.7 | |
| $664B | -2245.8 | 59.6 | — | 34.8% | -0.0% | -0.2% | -0.0% | 4.0 | |
| $1.8T | 79.7 | 54.2 | 67.2 | 67.8% | 39.9% | 31.0% | 14.9% | 1.9 | |
| $70B | 111.7 | 88.3 | 105.0 | 55.2% | 26.1% | 18.4% | 22.2% | 0.0 | |
| Technology Median | — | 28.3 | 16.5 | 19.0 | 49.0% | -0.2% | 1.7% | 2.6% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 4 years · Updated daily
Deep dive into ALAB consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALAB stock.
Astera Labs, Inc. Common Stock's current P/E ratio is 325.4x. The historical average is 136.4x. This places it at the 100th percentile of its historical range.
Astera Labs, Inc. Common Stock's current EV/EBITDA is 374.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA.
Astera Labs, Inc. Common Stock's return on equity (ROE) is 18.8%. The historical average is -22.9%.
Based on historical data, Astera Labs, Inc. Common Stock is trading at a P/E of 325.4x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Astera Labs, Inc. Common Stock has 75.7% gross margin and 20.3% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Astera Labs, Inc. Common Stock's Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.